AMT-253 in Patients With Selected Advanced Solid Tumours
NCT 05906862 Brief Summary This first-in-human study will evaluate the Maximum Tolerated…
Read more arrow_forwardNCT 05906862 Brief Summary This first-in-human study will evaluate the Maximum Tolerated…
Read more arrow_forwardNCT 03175224 Brief Summary To assess: efficacy of APL-101 as monotherapy for…
Read more arrow_forwardNCT 05807035 Brief Summary Phase 1 trial to evaluate the feasibility of…
Read more arrow_forwardNCT 06219941 Brief Summary The purpose of this study is to assess…
Read more arrow_forwardNCT 06120283 Brief Summary This is a dose escalation and dose expansion…
Read more arrow_forwardNCT 05440786 Intervention / Treatment Drug: Abemaciclib Drug: Irinotecan Drug: Temozolomide Inclusion Criteria Diagnosis of…
Read more arrow_forwardNCT 05868174 Brief Summary This is an open label, single-arm, multicentre dose…
Read more arrow_forwardNCT 05756907 Brief Summary This is a Phase 1b/2a, open-label, adaptive-design…
Read more arrow_forwardNCT 05598151 Brief Summary This is a Phase1 study to assess the…
Read more arrow_forwardNCT 05607498 Brief Summary For solid tumors and lymphoma, respectively: This study…
Read more arrow_forward